• Der Radiologe · Jul 2001

    [Differential diagnostic problems in assessment of benign bone tumors].

    • S Lang and I Sulzbacher.
    • Institut für Klinische Pathologie, Universität Wien, Währinger Gürtel 18-20, 1090 Wien/Osterreich.
    • Radiologe. 2001 Jul 1; 41 (7): 533-9.

    AbstractThe diagnosis of benign bone tumors can cause many problems and a definitive histological diagnosis is often impossible without the knowledge of clinical datas, age of the patient and anatomical location of the tumor. Therefor cooperation between pathologist, orthopedic surgeon and radiologist is necessary, to reduce the risk of misinterpretation of benign and malignant bone tumors. Benign bone tumors often show a heterogenous histology and overlapping morphology between different entities has to be kept in mind, as well as the sampling error in biopsy- and frozen section material. In most cases the pathologist has to rely on conventional stainings because the immunohistochemistry stainings are often not helpful.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.